| Proteomic reference map for sarcopenia research: mass spectrometric identification of key muscle proteins located in the sarcomere, cytoskeleton and the extracellular matrix P Dowling, S Gargan, M Zweyer, M Henry, P Meleady, D Swandulla, ... European journal of translational myology, 2024 | | 2024 |
| Evaluating the clinical utility of apitolisib/vorinostat combination in apitolisib-resistant H1975 lung adenocarcinoma A Hmmier, P Dowling | | 2024 |
| The potential of proteomics for in-depth bioanalytical investigations of satellite cell function in applied myology P Dowling, C Trollet, L Muraine, E Negroni, D Swandulla, K Ohlendieck Expert Review of Proteomics, 2024 | | 2024 |
| Multiple Myeloma: Molecular Mechanism and Targeted Therapy D Bazou, P Dowling International Journal of Molecular Sciences 25 (7), 3799, 2024 | | 2024 |
| Type 1 interferon auto-antibodies are elevated in patients with decompensated liver cirrhosis G Greville, S Cremen, S O’Neill, S Azarian, G Brady, W McCormack, ... Clinical and Experimental Immunology 215 (2), 177-189, 2024 | | 2024 |
| How Can Proteomics Help to Elucidate the Pathophysiological Crosstalk in Muscular Dystrophy and Associated Multi-System Dysfunction? P Dowling, C Trollet, E Negroni, D Swandulla, K Ohlendieck Proteomes 12 (1), 4, 2024 | 1 | 2024 |
| Sample preparation for proteomics and mass spectrometry from clinical tissue S Gargan, P Dowling, K Ohlendieck Proteomics Mass Spectrometry Methods, 55-77, 2024 | | 2024 |
| Profiling of the phosphoproteome using tandem mass tag labeling K Dunphy, P Dowling Proteomics Mass Spectrometry Methods, 163-172, 2024 | | 2024 |
| Cellular pathogenesis of Duchenne muscular dystrophy: progressive myofibre degeneration, chronic inflammation, reactive myofibrosis and satellite cell dysfunction P Dowling, D Swandulla, K Ohlendieck European Journal of Translational Myology 33 (4), 2023 | 2 | 2023 |
| Mass spectrometry-based proteomic technology and its application to study skeletal muscle cell biology P Dowling, D Swandulla, K Ohlendieck Cells 12 (21), 2560, 2023 | 3 | 2023 |
| Correction: PP2A inhibition overcomes acquired resistance to HER2 targeted therapy MSJ McDermott, BC Browne, NT Conlon, NA O’Brien, DJ Slamon, ... Molecular Cancer 22 (1), 175, 2023 | | 2023 |
| Using proteomics data to identify personalized treatments in multiple myeloma: A machine learning approach A Katsenou, R O’Farrell, P Dowling, CA Heckman, P O’Gorman, D Bazou International Journal of Molecular Sciences 24 (21), 15570, 2023 | 2 | 2023 |
| Proteomic profiling of the brain from the wobbler mouse model of amyotrophic lateral sclerosis reveals elevated levels of the astrogliosis marker glial fibrillary acidic protein S Murphy, T Schmitt-John, P Dowling, M Henry, P Meleady, D Swandulla, ... European Journal of Translational Myology 33 (3), 2023 | 1 | 2023 |
| Mass spectrometry-based proteomic characterization of the middle-aged mouse brain for animal model research of neuromuscular diseases P Dowling, M Zweyer, H Sabir, M Henry, P Meleady, D Swandulla, ... European journal of translational myology 33 (3), 2023 | 2 | 2023 |
| Biochemical and proteomic insights into sarcoplasmic reticulum Ca2+-ATPase complexes in skeletal muscles P Dowling, D Swandulla, K Ohlendieck Expert Review of Proteomics 20 (7-9), 125-142, 2023 | 2 | 2023 |
| Proteomic and metabolomic analysis of bone marrow and plasma from patients with extramedullary multiple myeloma identifies distinct protein and metabolite signatures K Dunphy, D Bazou, M Henry, P Meleady, JJ Miettinen, CA Heckman, ... Cancers 15 (15), 3764, 2023 | 2 | 2023 |
| Extracellular Matrix Proteomics: The mdx-4cv Mouse Diaphragm as a Surrogate for Studying Myofibrosis in Dystrophinopathy P Dowling, S Gargan, M Zweyer, D Swandulla, K Ohlendieck Biomolecules 13 (7), 1108, 2023 | 6 | 2023 |
| Dynamics of CXCR4 positive circulating tumor cells in prostate cancer patients during radiotherapy D Klusa, F Lohaus, A Franken, M Baumbach, M Cojoc, P Dowling, ... International Journal of Cancer 152 (12), 2639-2654, 2023 | 7 | 2023 |
| Analysis of Cancer Cell Line Secretomes: A Complementary Source of Disease-Specific Protein Biomarkers K Dunphy, D Bazou, P Dowling Cancer Cell Culture: Methods and Protocols, 277-287, 2023 | | 2023 |
| Cell and molecular actors of fibrosis in muscle diseases. C Trollet, M Bensalah, L Muraine, A Boulinguiez, P Dowling, JLS Guily, ... European Journal of Translational Myology 33 (2), 2023 | | 2023 |
